Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The Swedish MS registry - clinical support tool and scientific resource.
Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes.
Subject-Specific Sparse Dictionary Learning for Atlas-Based Brain MRI Segmentation.
The risk of developing depression when suffering from neurological diseases.
Epstein-Barr virus and multiple sclerosis: association or causation?
Downregulation of cystathionine β-synthase/hydrogen sulfide contributes to rotenone-induced microglia polarization toward M1 type.
Recent advances in treating multiple sclerosis: efficacy, risks and place in therapy.
Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis.
Immunoadsorption therapy for neuromyelitis optica spectrum disorders long after the acute phase.
In vivo-generated antigen-specific regulatory T cells treat autoimmunity without compromising antibacterial immune response.
Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis.
Madariaga Virus Infection Associated with a Case of Acute Disseminated Encephalomyelitis.
Progressive degeneration of the retinal nerve fiber layer in patients with multiple sclerosis.
Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis.
Changes in B and T-cell subsets and NMO-IgG levels after immunoglobulins and rituximab treatment for an acute attack of neuromyelitis optica.
Antenarratives to inform health care research: exploring workplace illness disclosure for people with multiple sclerosis (MS).
[Consensus document on spasticity in patients with multiple sclerosis.]
Spin echo transverse relaxation and atrophy in multiple sclerosis deep gray matter: A two-year longitudinal study.
Role of a novel HLA-DQA1*01:02;DRB1*15:01 mixed-isotype heterodimer in the pathogenesis of 'humanized' multiple sclerosis-like disease.
Multiple sclerosis: individualized disease susceptibility and therapy response.
Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis.
Examining Trait Mindfulness, Emotion Dysregulation, and Quality of Life in Multiple Sclerosis.
Erratum to: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.
Natalizumab reduces relapse clinical severity and improves relapse recovery in MS.
MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: an overview of current knowledge.

Pages